Le Lézard
Classified in: Health, Science and technology, Business
Subjects: PDT, MAT

Dragonfly Biosciences Ltd Expands CBD Portfolio


Range of DragonflyCBD® Flavoured Oils Launched

LONDON, Jan. 28, 2020 /PRNewswire/ --

From 4th February 2020, DragonflyCBD® will be expanding its scope of Cannabidiol (CBD) Oils to include a range of limited edition flavoured variants:

The new DragonflyCBD® Flavoured Range of Oils will be available via dragonflycbd.com and will join the existing DragonflyCBD® range, which is currently also available in full via the company's e-commerce platform.

The four new limited edition DragonflyCBD® Flavoured Range of Oils are formulated with 500mg Narrow-Spectrum CBD extract per 10ml bottle. With a lighter taste and consistency, the Narrow-Spectrum formulation from DragonflyCBD® is an ideal base for taking on the punchy, natural flavourings used in this range.

Chief Operating Officer for Dragonfly Biosciences, Hannah Skingle noted: "At Dragonfly Biosciences we are committed to supplying and empowering the CBD community by creating high-quality products and driving market sector innovation. Through insights from ongoing consumer research, there is a great need on the market to supply CBD in varying formats, flavours and tastes. We believe our new range of four flavoured oils, which will initially be launched as part of a limited edition initiative, will help make CBD more accessible to the growing numbers of people keen to try the compound."

Headquartered in the UK, Dragonfly Biosciences is one of the largest producers of CBD products in Europe. It is also one of the few companies that controls every stage of the process, from farming through to extraction and product formulation. Every product comes with across-the-board certification and compliance (non-GMO, GMP manufactured, THC-free), ensuring high-grade CBD every time.

Hannah Skingle is available for interview to discuss DragonflyCBD® and recent developments in the booming UK CBD market.

For more information, please visit https://dragonflycbd.com.

NOTES TO EDITORS

Product information
Orange 500mg (5%) 10ml - RRP £40
Mint 500mg (5%) 10ml - RRP £40
Anise 500mg (5%) 10ml - RRP £40
Cinnamon 500mg (5%) 10ml - RRP £40

About Dragonfly Biosciences

Dragonfly Biosciences is a leading producer of CBD and Cannabis-derived extracts. It nurtures all its products from seed to shelf: growing Cannabis sativa L. organically, using a unique extraction process and formulating under GMP conditions. Its range of DragonflyCBD® oil is available to buy from leading pharmacy-chains, independent pharmacies and leading supermarkets in strengths of 270mg to 2000mg. Supplying both branded products and bulk formulations, Dragonfly Biosciences hopes to set the bar for quality and build a responsible industry from the grass roots up.

Media Contact:
+44-(0)20-7111-0807
[email protected]


These press releases may also interest you

at 08:15
Masimo will release first quarter 2024 financial results for the period ended March 30, 2024, after the market closes on Tuesday, May 7, 2024. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by...

at 08:10
Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designations for sevasemten for the treatment of Becker muscular dystrophy (Becker)...

at 08:10
Tentarix Biotherapeutics today announced the appointment of Andrew Kidd, MD, as chief executive officer. Mr. Kidd joins Tentarix with a distinguished career of over two decades of executive and biotech experience. He was most recently the president...

at 08:09
Perrigo Company plc , a leading provider of Consumer Self-Care Products, today announced that it plans to issue its first quarter 2024 financial results on Tuesday, May 7th, 2024, and host a conference call beginning at 8:30 A.M. (EDT)....

at 08:07
While many individuals are familiar with acupuncture and may have experienced it firsthand, few possess a deep comprehension of its underlying mechanisms or how it diverges from conventional medical practices in its approach.  Acupuncturist, medical...

at 08:05
CG Life specialty marketing communications agency Element CG, formerly The Market Element, today announced a brand relaunch to align more closely with its focus on supporting emerging life sciences and biopharma companies with scientific marketing...



News published on and distributed by: